Literature DB >> 20810663

Tumor suppressor ras association domain family 5 (RASSF5/NORE1) mediates death receptor ligand-induced apoptosis.

Jikyoung Park1, Soo Im Kang, Sun-Young Lee, Xian F Zhang, Myoung Shin Kim, Lisa F Beers, Dae-Sik Lim, Joseph Avruch, Ho-Shik Kim, Sean Bong Lee.   

Abstract

Epigenetic silencing of RASSF (Ras association domain family) genes RASSF1 and RASSF5 (also called NORE1) by CpG hypermethylation is found frequently in many cancers. Although the physiological roles of RASSF1 have been studied in some detail, the exact functions of RASSF5 are not well understood. Here, we show that RASSF5 plays an important role in mediating apoptosis in response to death receptor ligands, TNF-α and TNF-related apoptosis-inducing ligand. Depletion of RASSF5 by siRNA significantly reduced TNF-α-mediated apoptosis, likely through its interaction with proapoptotic kinase MST1, a mammalian homolog of Hippo. Consistent with this, siRNA knockdown of MST1 also resulted in resistance to TNF-α-induced apoptosis. To further study the role of Rassf5 in vivo, we generated Rassf5-deficient mouse. Inactivation of Rassf5 in mouse embryonic fibroblasts (MEFs) resulted in resistance to TNF-α- and TNF-related apoptosis-inducing ligand-mediated apoptosis. Importantly, Rassf5-null mice were significantly more resistant to TNF-α-induced apoptosis and failed to activate Mst1. Loss of Rassf5 also resulted in spontaneous immortalization of MEFs at earlier passages than the control MEFs, and Rassf5-null immortalized MEFs, but not the immortalized wild type MEFs, were fully transformed by K-RasG12V. Together, our results demonstrate a direct role for RASSF5 in death receptor ligand-mediated apoptosis and provide further evidence for RASSF5 as a tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20810663      PMCID: PMC2966117          DOI: 10.1074/jbc.M110.165506

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1.

Authors:  Sara Ortiz-Vega; Andrei Khokhlatchev; Maria Nedwidek; Xian-feng Zhang; Reinhard Dammann; Gerd P Pfeifer; Joseph Avruch
Journal:  Oncogene       Date:  2002-02-21       Impact factor: 9.867

2.  Death-associated protein 4 binds MST1 and augments MST1-induced apoptosis.

Authors:  Yenshou Lin; Andrei Khokhlatchev; Daniel Figeys; Joseph Avruch
Journal:  J Biol Chem       Date:  2002-10-15       Impact factor: 5.157

3.  Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

Authors:  R Dammann; C Li; J H Yoon; P L Chin; S Bates; G P Pfeifer
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

4.  Identification of a novel Ras-regulated proapoptotic pathway.

Authors:  Andrei Khokhlatchev; Shahrooz Rabizadeh; Ramnik Xavier; Maria Nedwidek; Tao Chen; Xian-feng Zhang; Brian Seed; Joseph Avruch
Journal:  Curr Biol       Date:  2002-02-19       Impact factor: 10.834

5.  NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers.

Authors:  Luke Hesson; Ashraf Dallol; John D Minna; Eamonn R Maher; Farida Latif
Journal:  Oncogene       Date:  2003-02-13       Impact factor: 9.867

6.  RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1.

Authors:  Stella Tommasi; Reinhard Dammann; Seung-Gi Jin; Xian-feng Zhang; Joseph Avruch; Gerd P Pfeifer
Journal:  Oncogene       Date:  2002-04-18       Impact factor: 9.867

7.  The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation.

Authors:  Latha Shivakumar; John Minna; Toshiyuki Sakamaki; Richard Pestell; Michael A White
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

8.  Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.

Authors:  Mark R Morris; Luke B Hesson; Kate J Wagner; Neil V Morgan; Dewi Astuti; Robert D Lees; Wendy N Cooper; JouAnn Lee; Dean Gentle; Fiona Macdonald; Takeshi Kishida; Richard Grundy; Masahiro Yao; Farida Latif; Eamonn R Maher
Journal:  Oncogene       Date:  2003-10-02       Impact factor: 9.867

9.  Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase.

Authors:  Wang L Cheung; Kozo Ajiro; Kumiko Samejima; Malgorzata Kloc; Peter Cheung; Craig A Mizzen; Alexander Beeser; Laurence D Etkin; Jonathan Chernoff; William C Earnshaw; C David Allis
Journal:  Cell       Date:  2003-05-16       Impact factor: 41.582

10.  The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death.

Authors:  Shairaz Baksh; Stella Tommasi; Sarah Fenton; Victor C Yu; L Miguel Martins; Gerd P Pfeifer; Farida Latif; Julian Downward; Benjamin G Neel
Journal:  Mol Cell       Date:  2005-06-10       Impact factor: 17.970

View more
  35 in total

1.  NORE1A sensitises cancer cells to sorafenib-induced apoptosis and indicates hepatocellular carcinoma prognosis.

Authors:  Li-Li Liu; Mei-Fang Zhang; Ying-Hua Pan; Jing-Ping Yun; Chris Zhiyi Zhang
Journal:  Tumour Biol       Date:  2014-02-25

2.  Netrin-1 exerts oncogenic activities through enhancing Yes-associated protein stability.

Authors:  Qi Qi; Dean Y Li; Hongbo R Luo; Kun-Liang Guan; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-26       Impact factor: 11.205

3.  Rassf5 and Ndr kinases regulate neuronal polarity through Par3 phosphorylation in a novel pathway.

Authors:  Rui Yang; Eryan Kong; Jing Jin; Alexander Hergovich; Andreas W Püschel
Journal:  J Cell Sci       Date:  2014-06-13       Impact factor: 5.285

Review 4.  Protein kinases of the Hippo pathway: regulation and substrates.

Authors:  Joseph Avruch; Dawang Zhou; Julien Fitamant; Nabeel Bardeesy; Fan Mou; Laura Regué Barrufet
Journal:  Semin Cell Dev Biol       Date:  2012-08-09       Impact factor: 7.727

Review 5.  MST1/MST2 Protein Kinases: Regulation and Physiologic Roles.

Authors:  Jacob A Galan; Joseph Avruch
Journal:  Biochemistry       Date:  2016-09-26       Impact factor: 3.162

Review 6.  Pumping the brakes on RAS - negative regulators and death effectors of RAS.

Authors:  Desmond R Harrell Stewart; Geoffrey J Clark
Journal:  J Cell Sci       Date:  2020-02-10       Impact factor: 5.285

Review 7.  Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

Authors:  Yunli Zhou; Xun Zhang; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

Review 8.  Ras signaling through RASSF proteins.

Authors:  Howard Donninger; M Lee Schmidt; Jessica Mezzanotte; Thibaut Barnoud; Geoffrey J Clark
Journal:  Semin Cell Dev Biol       Date:  2016-06-08       Impact factor: 7.727

9.  Ras Regulates Rb via NORE1A.

Authors:  Thibaut Barnoud; Howard Donninger; Geoffrey J Clark
Journal:  J Biol Chem       Date:  2015-12-16       Impact factor: 5.157

10.  Role of mitofusin 2 (Mfn2) in controlling cellular proliferation.

Authors:  Kuang-Hueih Chen; Asish Dasgupta; Jinhui Ding; Fred E Indig; Paritosh Ghosh; Dan L Longo
Journal:  FASEB J       Date:  2013-09-30       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.